Advertisement
Screener

OMEROS CORP (OMER) ROI

OMEROS CORP (OMER) ROI

  • 2018-09-30: ROI -276.88%.
  • 2018-06-30: ROI -118.53%.
  • 2018-03-31: ROI -121.50%.
  • 2017-12-31: ROI -65.39%.

Complete source-backed roi history.

Available history
2011-12-31 to 2018-09-30
Data captured

Historical ROI

DateROI
2018-09-30-276.88%
2018-06-30-118.53%
2018-03-31-121.50%
2017-12-31-65.39%
2017-09-30-61.24%
2017-06-30-234.26%
2017-03-31-187.92%
2016-12-31-157.93%
2016-09-30-140.31%
2016-06-30-346.62%
2016-03-31-827.59%
2015-12-31-318.10%
2015-09-30-388.72%
2015-06-30-192.20%
2015-03-31-138.21%
2014-12-31722.21%
2014-09-30-920.63%
2014-06-30-231.39%
2014-03-31-122.78%
2013-12-31-1882.50%
2013-09-301306.03%
2013-06-30-560.97%
2013-03-31-924.02%
2012-12-31-283.26%
2011-12-31-205.49%

Annual ROI

DateROI
2017-12-31-65.39%
2016-12-31-157.93%
2015-12-31-318.10%
2014-12-31722.21%
2013-12-31-1882.50%
2012-12-31-283.26%
2011-12-31-205.49%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82